Cargando…
Cardiovascular-specific mortality among multiple myeloma patients: a population-based study
INTRODUCTION: Multiple myeloma (MM) survival has greatly improved in recent decades. MM is usually diagnosed at a median age of 66–70 years. MM patients do not necessarily die from primary cancer, so cardiovascular health may be a key factor threatening long-term survival. This study was designed to...
Autores principales: | Yin, Xuejiao, Fan, Fengjuan, Zhang, Bo, Hu, Yu, Sun, Chunyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978329/ https://www.ncbi.nlm.nih.gov/pubmed/35387110 http://dx.doi.org/10.1177/20406207221086755 |
Ejemplares similares
-
Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017
por: Yin, Xuejiao, et al.
Publicado: (2018) -
Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study
por: Yin, Xuejiao, et al.
Publicado: (2020) -
Corrigendum: Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study
por: Yin, Xuejiao, et al.
Publicado: (2021) -
Looking into Endoplasmic Reticulum Stress: The Key to Drug-Resistance of Multiple Myeloma?
por: Wang, Guangqi, et al.
Publicado: (2022) -
Prognostic role of neutrophil–lymphocyte ratio in multiple myeloma: a dose–response meta-analysis
por: Mu, Shidai, et al.
Publicado: (2018)